WraSer Pharmaceuticals, LLC agrees to promote three key branded topical dermatology products for Ranbaxy Laboratories, Inc.

WraSer Pharmaceuticals, LLC agrees to promote three key branded topical dermatology products for Ranbaxy Laboratories, Inc.


MADISON, MS – October 24, 2008 – WraSer Pharmaceuticals, LLC (WraSer) a privately held Madison, Mississippi based pharmaceutical company, is pleased to announce it has entered into a strategic relationship with Ranbaxy Laboratories, Inc., (Ranbaxy), a wholly-owned subsidiary of Ranbaxy Labs, Ltd, NYSE: RANBAXY.NS, to co-promote three of Ranbaxy’s branded dermatological products in the United States. 


WraSer Pharmaceuticals will target primary care medical practitioners to increase the market for Ranbaxy’s Halog® Cream and Ointment, a class 2 high-potency topical steroid; Exelderm® Cream and Solution, a broad-spectrum imidazole anti-fungal; and Eurax® Cream and Lotion, a non-steroidal, prescription anti-pruritic. . 


“We are very excited to bring these proven, effective products to our primary care markets,” said Heath Wray, Co-Founder and President of WraSer Pharmaceuticals.  “We believe that we can significantly increase the value of these brands for our partner, Ranbaxy, while providing high-quality dermatological care to our customer base of physicians and their patients.”


Ranbaxy acquired Halog®, Exelderm® and Eurax®, along with several other dermatological products, from Bristol-Myers Squibb in 2007 to extend its reach into the U.S. dermatology market.  To date, Ranbaxy has focused its efforts on promoting these brands within the dermatology practice specialty only.  While Ranbaxy will continue this promotional effort, the relationship with WraSer broadens the promotional effort into the primary care markets, which account for a large percentage of dermatological prescriptions written in the U.S.


About WraSer Pharmaceuticals, LLC

WraSer Pharmaceuticals, LLC (Wraser), based in Madison, MS, is a specialty pharmaceutical company engaged in the development and marketing of prescription pharmaceutical products.  Founded in 2002, WraSer has built a strong presence in the pharmaceutical markets by offering a variety of innovative, affordable products to medical practitioners and their patients.  For more information, please visit www.wraser.com.


About Ranbaxy Laboratories, Inc.

Ranbaxy Laboratories, Inc. (RLI) based in Princeton, New Jersey, is a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), India’s largest pharmaceutical company. RLI is engaged in the sale and distribution of branded prescription products in the U.S. healthcare system.  For more information, please see our website at www.ranbaxyusa.com. 



Posted on 12/8/2008

View All Postings